If you have cancer, chances are your outpatient chemotherapy treatment costs are higher if your oncologist works for a health care system than if she has her own practice, a recent study found
Most consumers don’t believe the adage that “you get what you pay for” in health care, according to a new study.
By teaming with community organizations, doctors and hospitals can deliver high-quality care at good value to disadvantaged people at risk for poor health, according to a new report from a panel of experts.
Talking about money is never easy.
Drug treatment providers in California and elsewhere have relied for decades on abstinence and therapy to treat addicts. In recent years, they’ve turned to medication.
Tucked in remarks the president made Tuesday on the opioid epidemic was his announcement of a
More wages, less health insurance. In a recent survey, one in five people with employer-based coverage said they would opt for fewer health benefits if they could get a bump in their wages. That’s double the percentage who said they would make that choice in 2012.
When California’s aid-in-dying law takes effect this June, terminally ill patients who decide to end their lives could be faced with a hefty bill for the lethal medication. It retails for more than $3,000.
Valeant Pharmaceuticals, the company that makes the drug most commonly prescribed by physicians to aid patients who want to end their lives, doubled the drug’s price last year, one month after California lawmakers proposed legalizing the practice.
On the sixth anniversary of the enactment of the federal Affordable Care Act, the law was back before a seemingly divided Supreme Court Wednesday.
As the health law turned six Wednesday, federal officials proposed the expansion of a Medicare diabetes prevention program funded by the landmark measure.
